The Arizona Innovation Challenge (AIC), one of the largest business plan competitions in the country, is designed to advance innovation and technology commercialization opportunities in Arizona by assisting early-stage ventures to scale. All applicants receive feedback on their business plan from experienced entrepreneurial judges.
AIC awardees receive $100,000 of non-dilutive funding and three months of customized support with an ACA-designated partner.Continue reading
Transforming Global Oncology from the Heart of Arizona:
Arizona Bioscience Company of the Year – TD2 OncologyContinue reading
A vital lifeline to patients facing end-stage biventricular heart failure.
For millions of people worldwide, cardiac health is something taken for granted—a steady, rhythmic beat keeping life in motion. But for patients diagnosed with advanced biventricular heart failure, that rhythm slows to a dangerous point. When both the left and right ventricles can no longer pump enough blood to sustain vital organs, the threat of imminent death becomes an immediate reality.
In these critical moments, modern medical technology steps in with a groundbreaking solution: the SynCardia Total Artificial Heart (STAH)Continue reading
He learned to be a scientist as a teenager. Now he seeks a cure for a childhood cancerContinue reading
Dr. Eric M. Reiman’s groundbreaking work transformed Alzheimer’s research and positioned Banner as a global leader in detection, prevention studiesContinue reading
Federal funding backs engineering to advance the wireless and radio-frequency systems for the wearable toward manufacturing at scale, in partnership with the University of ArizonaContinue reading
Detecting Cancer Before It Starts: How One Arizona Startup Is Transforming Precision Oncology
In modern medicine, early cancer detection remains a central goal. Identifying a tumor before symptoms emerge often makes the difference between routine intervention and a terminal diagnosis.
Standing at the leading edge of this shift is Precision Epigenomics, a Tucson-based bioscience startup whose rapid trajectory over the past 18 months is drawing national attention. Through cutting-edge liquid biopsy technology, rigorous laboratory standards, and high-impact strategic partnerships, the company is turning complex epigenetic science into life-saving clinical tools.Continue reading
As Arizona enters another respiratory virus season, physicians will once again navigate patient questions surrounding influenza, SARS-CoV-2, and respiratory syncytial virus (RSV) immunization. In an environment of evolving recommendations and competing information, access to rigorous, transparent evidence is essential to informed clinical decision-making.Continue reading
Employees of AZBio Member Companies and their dependents can now get a 15% scholarship for over 400 undergraduate degrees, graduate degrees, and certificates offered by ASU Online.
Learn more at AZBio.org/InStrideContinue reading